Antibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections

Drugs

Volumn 72, Issue 3, 2012, Pages 339-351

  Forcade, Nicolas A ^a,b   Wiederhold, Nathan P ^a,b   Ryan, Laurajo ^a,b   Talbert, Robert L ^a,b   Frei, Christopher R ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Antibacterials; Cefalexin; Cephalosporins; Clindamycin; Cotrimoxazole; Methicillin resistant Staphylococcus aureus infections; Skin and soft tissue infections.

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CEFRADINE; CLINDAMYCIN; COTRIMOXAZOLE; TETRACYCLINE;

ANTIMICROBIAL THERAPY; BACTERIAL SKIN DISEASE; CHILDHOOD DISEASE; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; COMMUNITY CARE; COMPARATIVE EFFECTIVENESS; DEBRIDEMENT; FOLLOW UP; HUMAN; INCISION AND DRAINAGE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; NONHUMAN; OBSERVATIONAL STUDY; PRESCRIPTION; REVIEW; SKIN ABSCESS; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; SUPERFICIAL ABSCESS; SUPPURATION; SURGICAL DRAINAGE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; DRAINAGE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84856717654     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11599510-000000000-00000     Document Type: Review

References (37)

1. Hersh AL, Chambers HF, Maselli JH, et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168: 1585-91
2. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillinresistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74
3. Tillotson GS, Draghi DC, Sahm DF, et al. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study. J Antimicrob Chemother 2008; 62: 109-15 (Pubitemid 351865881)
4. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41: 1373-406 (Pubitemid 41581713)
5. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52: E18-55
6. Taira BR, Singer AJ, Thode Jr HC, et al. National epidemiology of cutaneous abscesses: 1996 to 2005. Am J Emerg Med 2009; 27: 289-92
7. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007; 51: 4044-8 (Pubitemid 350057804)
8. Szumowski JD, Cohen DE, Kanaya F, et al. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007; 51: 423-8 (Pubitemid 46185256)
9. Paydar KZ, Hansen SL, Charlebois ED, et al. Inappropriate antibiotic use in soft tissue infections. Arch Surg 2006; 141: 850-4; discussion 5-6 (Pubitemid 44414426)
10. Frei CR, Miller ML, Lewis 2nd JS, et al. Trimethoprimsulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. J Am Board FamMed 2010; 23: 714-9
11. SchmitzGR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med 2010; 56: 283-7
12. King MD, Humphrey BJ, Wang YF, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006; 144: 309-17 (Pubitemid 46768185)
13. Frazee BW, Lynn J, Charlebois ED, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005; 45: 311-20 (Pubitemid 40261163)
14. Parchman ML, Munoz A. Risk factors for methicillinresistant Staphylococcal aureus skin and soft tissue infections presenting in primary care: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med 2009; 22: 375-9
15. Tattevin P, Diep BA, Jula M, et al. Methicillin-resistant Staphylococcus aureus USA300 in long-term care facility. Emerg Infect Dis 2009; 15: 953-5
16. DavidMZ, Gilkman P,Crawford SE, et al.What is communityassociated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197: 1235-43 (Pubitemid 351632754)
17. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008; 51: 291-8
18. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009; 15: 1516-8
19. Frei CR, Makos BR, Daniels KR, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg 2009; 45: 1967-74
20. Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis 2009; 15: 1925-30
21. Fridkin SK, Hageman JC, Morrison M, et al. Methicillinresistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-44
22. Gorwitz RJ, Jernigan DB, Powers JH, et al. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention 2006 [online]. Available from URL: http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca. html [Accessed 2011 May 05]
23. Ellis M. The use of penicillin and sulphonamides in the treatment of suppuration. Lancet 1951; 1: 774-5
24. Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, communityacquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44: 483-92 (Pubitemid 46233248)
25. Khawcharoenporn T, Tice A. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis. Am J Med 2010; 123: 942-50
26. Styers D, Sheehan DJ, Hogan P, et al. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006; 5: 2
27. Gupta K, Macintyre A, Vanasse G, et al. Trends in prescribing beta-lactam antibiotics for treatment of community- associated methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol 2007; 45: 3930-4 (Pubitemid 350274872)
28. Macfie J, Harvey J. The treatment of acute superficial abscesses: a prospective clinical trial. Br J Surg 1977; 64: 264-6 (Pubitemid 8075132)
29. Llera JL, Levy RC. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med 1985; 14: 15-9 (Pubitemid 15161258)
30. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23: 123-7 (Pubitemid 38222783)
31. Duong M, Markwell S, Peter J, et al. Randomized, controlled trial of antibiotics in the management of community- acquired skin abscesses in the pediatric patient. Ann Emerg Med 2010; 55: 401-7
32. Ruhe JJ, Smith N, Bradsher RW, et al. Community-onset methicillin-resistant Staphylococcus aureus skin and softtissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007; 44: 777-84 (Pubitemid 46365300)
33. Ruhe JJ, Menon A. Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 3298-303 (Pubitemid 350067543)
34. Frei CR, Miller ML, Forcade NA. Response: Re: Trimethprim- sulfamethoxazole or clindamycin for communityassociated MRSA (CA-MRSA) skin infections. J Am Board Fam Med 2011; 24: 332-3
35. National Institute of Allergy and Infectious Disesases (NIAID). Uncomplicated skin and soft tissue infections caused by community-associated methicillin-resistant Staphylococcus aureus [ClinicalTrials.gov identifier NCT00730028]. US National Institutes of Health,ClinicalTrials.gov [online].Available from URL: http://www.clinicaltrials.gov [Accessed 2012 Jan 9]
36. National Institute of Allergy and Infectious Disesases (NIAID). Strategies using off-patent antibiotics for methicillin resistant S. aureus 'STOP MRSA' [ClinicalTrials.gov identifier NCT00729937]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www. clinicaltrials.gov [Accessed 2012 Jan 9]
37. Gaspari RJ, Resop D, Mendoza M, et al. A randomized controlled trial of incision and drainage versus ultrasonographically guided needle aspiration for skin abscesses and the effect of methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2001; 57: 483-91